Community Consensus
Do you like PQQ?
Reflects reader sentiment, not medical advice or a recommendation.
Community Consensus
Also weighed here
Reader sentiment on the compounds this article compares. Votes count toward each compound's own tally.
- CoQ102.1k votes · 84%👍
Reader sentiment only. Not medical advice, not a recommendation, and not a measure of evidence quality.
Quick answer
PQQ (pyrroloquinoline quinone) is a small quinone compound found in trace amounts in natto, green tea, parsley, kiwi, and human breast milk. It is interesting because in cells and animals it appears to increase the number of mitochondria, not just protect existing ones, by raising PGC-1a signalling through CREB and SIRT1. That preclinical mechanism is solid and reproducible. The human evidence is the weak link: the four trials that exist enrolled 10 to 41 people, ran from three days to twelve weeks, and were nearly all industry-funded, with modest results scattered across different outcomes. PQQ is also not a vitamin, despite the label. That claim came from one 2003 Nature paper that was rebutted twice in the same journal in 2005. Treat PQQ as a plausible, low-risk, optional add-on with an unusually good story and unusually thin proof.
Key takeaways
- PQQ's distinguishing mechanism is mitochondrial biogenesis: it raises PGC-1a expression via CREB phosphorylation, the same master switch endurance exercise activates. Demonstrated in cells and rodents, never directly demonstrated in healthy humans.
- PQQ is vitamin-like, not a vitamin. The 2003 Nature paper proposing it as a new B vitamin was rebutted twice in Nature in 2005; no PQQ-dependent human enzyme has been confirmed and there is no RDA.
- All four human trials are small and short: 17 people open-label (2012), 10 people for three days (2013), 41 people for 12 weeks (2016), and 34 people for six weeks (2024). Nearly all were industry-funded.
- The best-designed trial (2024, mild cognitive impairment) raised BDNF, brain NAA, and cerebral oxygen saturation, but tested PQQ combined with magnesium in a hydrogen-producing formula, and general cognition did not beat placebo.
- A 20 mg capsule is roughly 50 to 200 times normal dietary intake (estimated 100 to 400 mcg/day, mostly from natto and green tea). This is a pharmacological dose, not dietary replacement.
- PQQ is a redox catalyst rather than a consumable antioxidant, cycling repeatedly without degrading, at a reported 100 to 1,000 times the efficiency of ascorbic acid in redox-cycling assays.
- Buy PQQ disodium salt, the form used in the trials and covered by FDA GRAS notifications and an EFSA novel-food assessment, and insist on an independent certificate of analysis for identity, potency, and heavy metals.
The short answer
PQQ (pyrroloquinoline quinone) is a small quinone compound found in trace amounts in fermented soy, parsley, green tea, kiwi, and human breast milk. It is interesting for one specific reason: in cells and animals it appears to increase the number of mitochondria rather than just protecting the ones you already have. That mechanism is real and reproducible in the lab. The human evidence is the weak link. Every meaningful human trial so far has been small (10 to 41 people), short (3 days to 12 weeks), and funded by an ingredient manufacturer, and the results have been modest and scattered across different outcomes. PQQ is a plausible, low-risk, optional add-on with an unusually good story and unusually thin proof.
⚠ CLAIM (wellness): PQQ stimulates mitochondrial biogenesis via CREB phosphorylation and increased PGC-1α expression in cell and rodent models. This is established preclinical biology. It is not a claim that PQQ supplements measurably increase mitochondrial number in healthy humans, which has never been directly demonstrated. Basis: Chowanadisai 2010; Saihara 2017. Lane: educational.
What PQQ actually is
PQQ is an o-quinone: a small, ring-shaped molecule that can accept and donate electrons. It was discovered in bacteria in the 1960s, where it serves as a genuine enzyme cofactor, the bacterial equivalent of a vitamin. In bacteria, PQQ-dependent dehydrogenases are real, well-characterized enzymes.
In mammals the picture is murkier, and that distinction matters more than most supplement pages admit. Humans do not make PQQ. We get small amounts from food and from gut bacteria. It shows up consistently in human breast milk, which is the strongest single argument that it does something useful, since the body does not tend to concentrate irrelevant molecules for infants.
Is PQQ a vitamin?
You will see PQQ called “vitamin B14” or “the newest B vitamin.” That label comes from one 2003 paper in Nature by Kasahara and Kato, which reported that a mouse enzyme in lysine metabolism was PQQ-dependent and concluded PQQ therefore qualified as a new B vitamin. It made headlines and it has been on labels ever since.
The problem is that the claim did not survive review. Two rebuttals published in Nature in 2005 took it apart. One showed the enzyme identification rested on a sequence-database artifact: beta-propeller protein folds were being labelled as PQQ-binding motifs when they are nothing of the sort. The other tried to reproduce the underlying biology and could not, finding that markers of lysine degradation were unaffected by PQQ status in rodents.
So the honest position is that PQQ is vitamin-like, not a vitamin. No PQQ-dependent enzyme has been confirmed in humans, no deficiency state has been defined, and there is no RDA. Anyone selling it as an established vitamin is repeating a 2003 headline that was corrected in 2005.
⚠ Contradiction: Kasahara & Kato (Nature, 2003) proposed PQQ as a new mammalian B vitamin based on a putative PQQ-dependent lysine-metabolism enzyme. Felton & Anthony (Nature, 2005) and Bauerly, Rucker and colleagues (Nature, 2005) rebutted it on bioinformatic and experimental grounds respectively. Both positions are kept here with provenance. The consensus that followed is “vitamin-like compound,” not vitamin. Lane: educational.
The mechanism that made PQQ interesting
The headline finding is mitochondrial biogenesis. In 2010, Chowanadisai and colleagues showed that PQQ exposure in mouse hepatocytes phosphorylated CREB, raised PGC-1α expression, and increased mitochondrial DNA content and respiratory-chain protein. A 2017 follow-up placed a SIRT1 step upstream of the same PGC-1α pathway.
PGC-1α is the master switch for building new mitochondria. It is the same regulator that Zone 2 endurance training turns on, which is exactly why PQQ gets marketed as “exercise in a capsule.” That framing oversells it badly, but the pathway really is the same one.
PQQ’s second property is redox stability. Most antioxidants are consumed when they neutralize something. PQQ cycles instead: it can be reduced and re-oxidized repeatedly without degrading or polymerizing. Redox-cycling assays put it in the range of 100 to 1,000 times more efficient than ascorbic acid at this. The often-repeated “20,000 cycles versus vitamin C’s 4” figure traces back to this literature, and while the exact numbers vary by assay, the qualitative point holds: PQQ behaves like a catalyst, not a consumable.
What PQQ is good for: the human evidence, honestly
There are four human trials worth knowing about. All of them are small.
| Study | Design | What it found |
|---|---|---|
| Nakano 2012 | 17 adults, 20 mg/day, 8 weeks, open label | Improvements in all six POMS mood measures, and in sleep onset, maintenance, and duration. No placebo arm. |
| Harris 2013 | 10 adults, 0.3 mg/kg, 3 days | CRP and IL-6 fell; urinary markers of mitochondrial-related metabolism shifted. Very short, very small. |
| Itoh 2016 | 41 elderly adults, 20 mg/day, 12 weeks, placebo-controlled | Improved selective attention and visuospatial cognition, mainly in participants who started with lower scores. |
| 2024 RCT (mild cognitive impairment) | 34 elderly adults, 20 mg twice daily plus magnesium, 6 weeks, placebo-controlled | Serum BDNF up 14.4%, ADAS-Cog orientation up 22.2%, cerebral oxygen saturation up 9.5%, NAA raised at 7 of 13 brain regions. General cognition (MMSE) did not beat placebo. |
Read that table the way a skeptic would. The 2012 study had no placebo group at all. The 2013 study ran for three days in ten people. The 2016 result was strongest in the subgroup that started worst, which is exactly where regression to the mean lives. And the 2024 trial, the best-designed of the four, tested PQQ combined with magnesium in a hydrogen-producing formulation, so you cannot cleanly attribute the result to PQQ, and its headline general-cognition measure did not separate from placebo.
What you are left with is a consistent direction of travel across mood, sleep, inflammatory markers, and brain metabolism, from studies too small to settle anything, mostly paid for by the people selling the ingredient. That is not nothing. It is also not proof, and the gap between those two things is where most PQQ marketing lives.
⚠ CLAIM (wellness): Small human trials of 20 mg/day PQQ have reported improvements in self-reported sleep and fatigue, reductions in CRP and IL-6, and modest gains in selective attention in older adults. Sample sizes range from 10 to 41, durations from 3 days to 12 weeks, and nearly all are industry-funded. These are preliminary signals, not established effects. Basis: Nakano 2012; Harris 2013; Itoh 2016; J Nutr Health Aging 2024. Lane: wellness-guidance.
Foods with PQQ, and why the gap matters
PQQ is widespread in food but present in microgram quantities. Natto (fermented soybeans) is the richest common source at roughly 60 to 70 mcg per 100 g. Green tea, parsley, green peppers, kiwi, papaya, and tofu contribute smaller amounts. Total dietary intake is usually estimated somewhere between 100 and 400 mcg per day.
A supplement capsule contains 20 mg. That is roughly 50 to 200 times a normal day’s dietary intake, and it is the single most important fact about PQQ supplementation. Nobody is “restoring” a dietary level here. Supplemental PQQ is a pharmacological dose of a compound we normally encounter in traces, and the consequences of taking it that way for years rather than weeks have not been studied in humans. Worth knowing before you decide.
PQQ and CoQ10
PQQ is sold next to CoQ10 more often than it is sold alone, on the reasoning that one builds mitochondria while the other helps them run. The logic is sound and the two genuinely do different jobs. What is missing is any rigorous human trial showing the combination outperforms either compound on its own. We broke that comparison out properly in PQQ vs CoQ10.
Buying PQQ: what actually matters
PQQ is one of the more expensive ingredients per gram in the mitochondrial category, which makes label accuracy worth caring about. Nearly all clinical work used PQQ disodium salt, the form with FDA GRAS notifications and an EFSA novel-food assessment behind it, so that is the form to look for. PQQ is also hygroscopic and light-sensitive, so packaging and freshness matter more than they do for a chemically stable commodity like taurine, though less than for a genuinely fragile active like astaxanthin.
Insist on an independent certificate of analysis confirming identity, potency, and heavy-metal screening, from a real third-party program rather than a self-issued “lab tested” badge on the bottle. Full detail in our guide to choosing a PQQ supplement.
How to think about it
If your actual goal is more mitochondria, the strongest and best-proven stimulus is still endurance exercise. It is free, it is potent, and the evidence behind it is not 34 people for six weeks. PQQ is a reasonable optional experiment to layer on top of a foundation that already includes training, sleep, and the better-evidenced compounds in our mitochondrial supplement guide. It is not a foundation itself.
Safety is genuinely reassuring at studied doses, with the caveat that “studied” means months rather than years, and that there is a specific kidney signal in high-dose rodent work worth understanding before you take it indefinitely. We covered that in PQQ side effects and safety.
The honest verdict
PQQ has one of the most interesting proposed mechanisms in the supplement aisle and one of the weakest human evidence bases relative to how confidently it is sold. Both of those are true at the same time, and most writing about PQQ picks one and ignores the other. Treat it as a promising experimental add-on, keep your expectations proportional to a handful of small industry-funded trials, and spend your first dollars on the things that are actually proven.
Educational information only, not medical advice, and not evaluated by the FDA. PQQ is not a treatment for any disease. Talk to a clinician before supplementing, particularly if you have reduced kidney function, are pregnant or breastfeeding, or take prescription medication.
Frequently asked questions
What is PQQ good for?
On current evidence, the honest answer is that nothing is established. Small human trials have reported better self-reported sleep and mood (17 people, no placebo group), lower CRP and IL-6 (10 people over three days), modest gains in selective attention and visuospatial cognition in older adults who started with lower scores (41 people over 12 weeks), and improved BDNF and brain metabolism markers in mild cognitive impairment (34 people over six weeks, in a combination formula). The direction is consistent; the studies are too small and too often industry-funded to be conclusive. Mechanistically, the interesting claim is mitochondrial biogenesis. This is educational information, not medical advice.
Is PQQ a vitamin?
No, despite frequently being labelled 'vitamin B14.' In 2003 Kasahara and Kato published in Nature that a mouse lysine-metabolism enzyme was PQQ-dependent, and concluded PQQ was a new B vitamin. Two rebuttals in Nature in 2005 dismantled it: one showed the enzyme identification came from a sequence-database artifact mislabelling beta-propeller folds as PQQ-binding motifs, and the other could not reproduce the underlying lysine-metabolism effect in rodents. No PQQ-dependent enzyme has been confirmed in humans, no deficiency state exists, and there is no RDA. The accurate term is 'vitamin-like compound.'
Does PQQ really create new mitochondria?
In cells and rodents, yes, by a reasonably well-characterized route. Chowanadisai and colleagues showed in 2010 that PQQ phosphorylates CREB, increases PGC-1a expression, and raises mitochondrial DNA content and respiratory-chain protein; a 2017 paper added a SIRT1 step upstream. Whether that translates into measurably more mitochondria in a healthy adult taking a capsule has never been tested directly. No human trial has measured mitochondrial density before and after PQQ supplementation. Endurance exercise activates the same PGC-1a pathway and has decades of human evidence behind it.
What foods contain PQQ?
Natto (fermented soybeans) is the richest common source at roughly 60 to 70 mcg per 100 g. Green tea contributes meaningfully, and parsley, green peppers, kiwi, papaya, tofu, and spinach contain smaller amounts. PQQ is also present in human breast milk, which is one of the better arguments that it does something physiologically useful. Total dietary intake is usually estimated at 100 to 400 mcg per day, which is 50 to 200 times less than a standard 20 mg supplement capsule.
Should I take PQQ with CoQ10?
The pairing is extremely common and the reasoning is sound: PQQ is proposed to help build mitochondria while CoQ10 supports the electron transport chain inside the ones you already have. They are not redundant. What is missing is any rigorous human trial showing the combination outperforms either compound taken alone, so the stack is mechanistically justified rather than evidence-backed. If you only want one, CoQ10 has considerably more human data behind it.
Is PQQ safe?
At the doses studied it appears well tolerated. PQQ disodium salt holds FDA GRAS notifications and was assessed by EFSA as a novel food at up to 20 mg per day. Reported side effects in trials are mild and infrequent. Two caveats are worth knowing: human safety data covers weeks to months rather than years, and high-dose rodent toxicology found reversible kidney changes in females, with an older study showing nephrotoxicity after injected doses far above anything used orally. Anyone with reduced kidney function should ask a clinician first. This is educational information, not medical advice.
How much PQQ do the studies use?
Almost all human work has used 20 mg per day of PQQ disodium salt, which is also the level EFSA assessed and the level most commercial products deliver. The 2013 inflammation study used 0.3 mg per kilogram of body weight, which works out close to the same figure for an average adult. The 2024 cognitive trial used 20 mg twice daily alongside magnesium. There is no established optimal dose and no evidence that more is better.
References
- 1.Chowanadisai W, Bauerly KA, Tchaparian E, et al. Pyrroloquinoline quinone stimulates mitochondrial biogenesis through CREB phosphorylation and increased PGC-1alpha expression. J Biol Chem. 2010;285(1):142-152.
- 2.Saihara K, Kamikubo R, Ikemoto K, Uchida K, Akagawa M. Pyrroloquinoline quinone, a redox-active o-quinone, stimulates mitochondrial biogenesis by activating the SIRT1/PGC-1alpha signaling pathway. Biochemistry. 2017;56(50):6615-6625.
- 3.Kasahara T, Kato T. A new redox-cofactor vitamin for mammals. Nature. 2003;422(6934):832.
- 4.Felton LM, Anthony C. Biochemistry: role of PQQ as a mammalian enzyme cofactor? Nature. 2005;433(7025):E10.
- 5.Bauerly KA, Storms DH, Harris CB, et al. Biochemistry: is pyrroloquinoline quinone a vitamin? Nature. 2005;433(7025):E10-E11.
- 6.Nakano M, Yamamoto T, Okamura H, Tsuda A, Kowatari Y. Effects of oral supplementation with pyrroloquinoline quinone on stress, fatigue, and sleep. Funct Foods Health Dis. 2012;2(8):307-324.
- 7.Harris CB, Chowanadisai W, Mishchuk DO, et al. Dietary pyrroloquinoline quinone (PQQ) alters indicators of inflammation and mitochondrial-related metabolism in human subjects. J Nutr Biochem. 2013;24(12):2076-2084.
- 8.Itoh Y, Hine K, Miura H, et al. Effect of the antioxidant supplement pyrroloquinoline quinone disodium salt (BioPQQ) on cognitive functions. Adv Exp Med Biol. 2016;876:319-325.
- 9.The impact of six-week dihydrogen-pyrroloquinoline quinone supplementation on mitochondrial biomarkers, brain metabolism, and cognition in elderly individuals with mild cognitive impairment: a randomized controlled trial. J Nutr Health Aging. 2024;28(8):100285.
- 10.EFSA Panel on Dietetic Products, Nutrition and Allergies. Safety of pyrroloquinoline quinone disodium salt as a novel food pursuant to Regulation (EC) No 258/97. EFSA Journal. 2017;15(11):5058.
- 11.US FDA. GRAS Notice No. 709: pyrroloquinoline quinone disodium salt (no-questions letter).
- 12.Akagawa M, Nakano M, Ikemoto K. Recent progress in studies on the health benefits of pyrroloquinoline quinone. Biosci Biotechnol Biochem. 2016;80(1):13-22.